| | Occupational Health Guidelines or the Evaluation and Control of |
| | 1,47 | | MB | Occupational Exposure to Nerve Agents GA, GB, GD, GF, and VX |
| | 93 | | stron |
| | 4579 | | ID | Department of Defense |
| | 2003 | | rok |
| | Contents |
| | Chapter 1 - Introduction |
| | Purpose 1-1 |
| | References 1-2 |
| | Explanation of abbreviations and terms 1-3 |
| | Background 1-4 |
| | Goals 1-5 |
| | Implementation 1-6 |
| | Waivers and exceptions 1-7 |
| | Technical assistance 1-8 |
| | Chapter 2 - Airborne Exposure Limits and Exposure Monitoring |
| | Introduction 2-1 |
| | Work practices 2-2 |
| | Airborne exposure limits 2-3 |
| | Exposure monitoring 2-4 |
| | Chapter 3 - Administrative Requirements |
| | Record keeping 3-1 |
| | Information and reporting requirements 3-2 |
| | Employee health education 3-3 |
| | Material safety data sheets 3-4 |
| | Chapter 4 – Nerve Agent Medical Surveillance Program |
| | Introduction 4-1 |
| | Nerve agent medical surveillance categories 4-2 |
| | Medical surveillance examinations 4-3 |
| | Post-offer, pre-placement examinations 4-4 |
| | Periodic job-related examinations 4-5 |
| | Termination examinations 4-6 |
| | Post-exposure and potential exposure evaluations 4-7 |
| | Documentation of medical opinion 4-8 |
| | Red blood cell-cholinesterase activity determinations 4-9 |
| | Appendices |
| | A. References |
| | B. Medical Surveillance Program for Personnel with a Significant Exposure Potential to Nerve |
| | Agents |
| | C. Medical Evaluation of Respirator Wearers and Potential Exposures to Nerve Agents |
| | D. Diagnosis and Treatment of Nerve Agent Intoxication |
| | E. Potential Exposure Evaluation Criteria for GB and VX Nerve Agents |
| | F. Toxicologic Basis for Derivation of Airborne Exposure Limits |
| | Glossary |